Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Cheson 2007 response criteria for lymphoma staging | Statement: [Lugano classification, replaced, Cheson 2007 response criteria for lymphoma staging]

Target entity: Cheson 2007 response criteria for lymphoma staging
Context triple: [Lugano classification, replaced, Cheson 2007 response criteria for lymphoma staging]

• A. R-CHOP
  R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
• B. Ann Arbor staging system
  The Ann Arbor staging system is a clinical classification method used to determine the extent and spread of lymphomas, particularly Hodgkin and non-Hodgkin lymphomas, within the body.
• C. non-Hodgkin lymphoma
  Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
• D. Leukemia and Lymphoma Research
  Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
• E. Hodgkin
  Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Cheson 2007 response criteria for lymphoma staging
Target entity description: The Cheson 2007 response criteria for lymphoma staging are standardized guidelines that defined how to assess treatment response and disease status in lymphoma patients using clinical, imaging, and laboratory parameters.

• A. R-CHOP
  R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
• B. Ann Arbor staging system
  The Ann Arbor staging system is a clinical classification method used to determine the extent and spread of lymphomas, particularly Hodgkin and non-Hodgkin lymphomas, within the body.
• C. non-Hodgkin lymphoma
  Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
• D. Leukemia and Lymphoma Research
  Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
• E. Hodgkin
  Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
• F. None of above. chosen